Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 87,548 |
|
|||||
| News | - | ||||||
| Day High | 4.28 | Low High |
|||||
| Day Low | 3.81 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Soligenix Inc | SNGX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.42 | 10.99% | 4.24 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.81 | 3.81 | 4.28 | 4.24 | 3.82 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 976 | 87,548 | US$ 4.08 | US$ 357,529 | - | 3.30 - 32.00 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:29:19 | 1 | US$ 4.19 | USD |
Soligenix Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 42.55M | 10.38M | - | 839k | -6.14M | -0.59 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Soligenix News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SNGX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.43 | 4.78 | 3.30 | 3.99 | 187,883 | 0.81 | 23.62% |
| 1 Month | 6.1312 | 7.04 | 3.30 | 5.20 | 325,782 | -1.89 | -30.85% |
| 3 Months | 9.92 | 14.9152 | 3.30 | 7.38 | 2,945,685 | -5.68 | -57.26% |
| 6 Months | 9.60 | 19.20 | 3.30 | 9.28 | 1,985,567 | -5.36 | -55.83% |
| 1 Year | 11.20 | 32.00 | 3.30 | 11.05 | 1,494,588 | -6.96 | -62.14% |
| 3 Years | 283.20 | 316.80 | 3.30 | 83.41 | 845,431 | -278.96 | -98.50% |
| 5 Years | 172.80 | 883.20 | 3.30 | 244.28 | 951,168 | -168.56 | -97.55% |
Soligenix Description
| Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19). |
